Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Succinylcholine
Drug ID BADD_D02079
Description Succinylcholine is a depolarizing skeletal muscle relaxant consisting of two molecules of the endogenous neurotransmitter [acetylcholine] (ACh) linked by their acetyl groups.[A19054] It has been widely used for over 50 years,[A299] most commonly in its chloride salt form, as a means of neuromuscular blockade during intubation and surgical procedures. Its rapid onset and offset, with effects beginning within 60 seconds of intravenous administration and lasting between four to six minutes, make succinylcholine particularly useful in the setting of short medical procedures requiring brief periods of muscle relaxation.[L9004]
Indications and Usage Used in surgical procedures where a rapid onset and brief duration of muscle relaxation is needed (includes intubation, endoscopies, and ECT)
Marketing Status Prescription; Discontinued
ATC Code M03AB01
DrugBank ID DB00202
KEGG ID C07546
MeSH ID D013390
PubChem ID 5314
TTD Drug ID D0Q7ZQ
NDC Product Code 71872-7241; 43598-666
Synonyms Succinylcholine | Succinyldicholine | Suxamethonium | Dicholine Succinate | Succinate, Dicholine | Quelicin | Succinylcholine Dichloride | Dichloride, Succinylcholine | Succinylcholine Dichloride, Di-H2O | Succinylcholine Dichloride, Di H2O | Succinylcholine Diiodide | Diiodide, Succinylcholine | Myorelaxin | Succinylcholine Diperchlorate | Diperchlorate, Succinylcholine | Succinylcholine Iodide | Suxamethonium Bromide | Bromide, Suxamethonium | Suxamethonium Chloride | Listenon | Succinylcholine Chloride | Anectine | Celocurine | Ditilin | Lysthenon | Succicuran | Succinylcholine Dibromide | Dibromide, Succinylcholine
Chemical Information
Molecular Formula C14H30N2O4+2
CAS Registry Number 306-40-1
SMILES C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
ApnoeaCholinesteraseP06276T99799Not Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anaphylactic reaction10.01.07.001; 24.06.03.0060.000130%
Anaphylactic shock24.06.02.004; 10.01.07.0020.000749%Not Available
Anaphylactoid reaction24.06.03.007; 10.01.07.003--Not Available
Apnoea22.02.01.001--
Arrhythmia02.03.02.001--Not Available
Body temperature increased13.15.01.001--Not Available
Bradycardia02.03.02.002--Not Available
Bronchospasm22.03.01.004; 10.01.03.0120.000375%
Cardiac arrest02.03.04.0010.000065%
Cough22.02.03.0010.000375%
Cyanosis24.03.01.007; 22.02.02.007; 02.01.02.0020.000250%
Dermatitis23.03.04.002--Not Available
Drug hypersensitivity10.01.01.0010.001748%Not Available
Flushing24.03.01.002; 23.06.05.003; 08.01.03.025--
Hyperkalaemia14.05.03.0010.000065%
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Hyperthermia malignant08.05.01.0020.000065%Not Available
Hypertonia17.05.02.001; 15.05.04.007--Not Available
Hypotension24.06.03.0020.000250%
Intraocular pressure increased13.07.04.002--Not Available
Laryngospasm22.04.02.0020.000250%
Muscle contractions involuntary15.05.03.008; 17.05.03.0010.000999%Not Available
Muscle rigidity17.05.02.005; 15.05.04.001--Not Available
Myalgia15.05.02.0010.000250%
Myasthenia gravis17.05.04.001; 15.05.08.001; 10.04.05.001--
Myoglobinuria20.02.01.010; 15.05.03.009; 02.04.02.006--Not Available
Myoglobin urine present13.16.02.002--Not Available
Neuromuscular block prolonged17.05.04.005; 12.02.12.0040.000499%Not Available
Pulmonary oedema22.01.03.003; 02.05.02.003--
The 1th Page    1 2    Next   Last    Total 2 Pages